(Q51378677)

4 April 2018

title

Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro. (English)

1 reference

4 April 2018

5

Jörg Heilmann

1 reference

4 April 2018

author name string

Michael Saugspier

1

1 reference

4 April 2018

Christoph Dorn

2

1 reference

4 April 2018

Wolfgang E Thasler

3

1 reference

4 April 2018

Manfred Gehrig

4

1 reference

4 April 2018

Claus Hellerbrand

6

1 reference

4 April 2018

publication date

25 November 2011

1 reference

4 April 2018

Experimental and Molecular Pathology

published in

1 reference

4 April 2018

volume

92

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

222-228

1 reference

4 April 2018

Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Hepatic stellate cell: a star cell in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Hepatic stellate cells as a target for the treatment of liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Tolerance and effects of lupulon in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Comparative study of hop-containing products on human cytochrome p450-mediated metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Mechanisms of hepatic fibrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Adipokines and cytokines in non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Detection of bile acids in thin-layer chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Transcriptional regulation of hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Inhibition of angiogenesis by humulone, a bitter acid from beer hop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Apoptosis to HL-60 by humulone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.11.005

10.1016/J.YEXMP.2011.11.005

7 January 2021

Identifiers

DOI

1 reference

4 April 2018

release_dxaumebknzdnjjhg5ownzn3huq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dxaumebknzdnjjhg5ownzn3huq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 April 2018